Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Alpha-synuclein research: defining strategic moves in the battle against Parkinson’s disease
Luís M. A. Oliveira, Thomas Gasser, Robert H. Edwards, et al.
npj Parkinson s Disease (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 114

Showing 1-25 of 114 citing articles:

Motor and non-motor circuit disturbances in early Parkinson disease: which happens first?
Javier Blesa, Guglielmo Foffani, Benjamin Dehay, et al.
Nature reviews. Neuroscience (2021) Vol. 23, Iss. 2, pp. 115-128
Closed Access | Times Cited: 157
Opportunities and challenges of alpha-synuclein as a potential biomarker for Parkinson’s disease and other synucleinopathies
Pedro Magalhães, Hilal A. Lashuel
npj Parkinson s Disease (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 92
Aggregate-prone brain regions in Parkinson’s disease are rich in unique N-terminus α-synuclein conformers with high proteolysis susceptibility
James A. Wiseman, Helen C. Murray, Richard L. M. Faull, et al.
npj Parkinson s Disease (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 25
Pharmacological Modulation of Nrf2/HO-1 Signaling Pathway as a Therapeutic Target of Parkinson’s Disease
Yumin Wang, Luyan Gao, Jichao Chen, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 75
Biofluid‐based biomarkers for Alzheimer's disease–related pathologies: An update and synthesis of the literature
Henrik Zetterberg
Alzheimer s & Dementia (2022) Vol. 18, Iss. 9, pp. 1687-1693
Open Access | Times Cited: 44
Lewy bodies, iron, inflammation and neuromelanin: pathological aspects underlying Parkinson’s disease
Peter Riederer, Toshiharu Nagatsu, Moussa B. H. Youdim, et al.
Journal of Neural Transmission (2023) Vol. 130, Iss. 5, pp. 627-646
Open Access | Times Cited: 35
Targeting Biomolecular Condensation and Protein Aggregation against Cancer
Jerson L. Silva, Débora Foguel, Vı́tor F. Ferreira, et al.
Chemical Reviews (2023) Vol. 123, Iss. 14, pp. 9094-9138
Closed Access | Times Cited: 35
Chemical Synthesis of Bioactive Proteins
Omer Harel, Muhammad Jbara
Angewandte Chemie International Edition (2023) Vol. 62, Iss. 13
Open Access | Times Cited: 31
Deep Learning-Assisted Single-Molecule Detection of Protein Post-translational Modifications with a Biological Nanopore
Chan Cao, Pedro Magalhães, Lucien F. Krapp, et al.
ACS Nano (2023) Vol. 18, Iss. 2, pp. 1504-1515
Open Access | Times Cited: 24
Multifaceted interactions mediated by intrinsically disordered regions play key roles in alpha synuclein aggregation
Sagar D. Khare, Priscilla Chinchilla, Jean Baum
Current Opinion in Structural Biology (2023) Vol. 80, pp. 102579-102579
Open Access | Times Cited: 23
HTRA1 disaggregates α-synuclein amyloid fibrils and converts them into non-toxic and seeding incompetent species
Sheng Chen, Anuradhika Puri, Braxton Bell, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 12
Nanopore: Emerging for detecting protein post-translational modifications
Xinjia Zhao, Haijuan Qin, Mingliang Tang, et al.
TrAC Trends in Analytical Chemistry (2024) Vol. 173, pp. 117658-117658
Closed Access | Times Cited: 9
Research Priorities on the Role of α‐Synuclein in Parkinson's Disease Pathogenesis
Jacqueline Burré, Robert H. Edwards, Glenda M. Halliday, et al.
Movement Disorders (2024) Vol. 39, Iss. 10, pp. 1663-1678
Open Access | Times Cited: 8
Identification of exosomal biomarkers and its optimal isolation and detection method for the diagnosis of Parkinson's disease: A systematic review and meta-analysis
Irin Sultana Nila, Dewan Md. Sumsuzzman, Zeeshan Ahmad Khan, et al.
Ageing Research Reviews (2022) Vol. 82, pp. 101764-101764
Closed Access | Times Cited: 36
Blood Markers of Inflammation, Neurodegeneration, and Cardiovascular Risk in Early Parkinson's Disease
Michael Bartl, Mohammed Dakna, Sebastian Schade, et al.
Movement Disorders (2022) Vol. 38, Iss. 1, pp. 68-81
Open Access | Times Cited: 36
Who Ever Said It Would Be Easy? Reflecting on Two Clinical Trials Targeting α‐Synuclein
Poul Henning Jensen, Michael G. Schlossmacher, Leonidas Stefanis
Movement Disorders (2023) Vol. 38, Iss. 3, pp. 378-384
Open Access | Times Cited: 18
Alpha synuclein post translational modifications: potential targets for Parkinson’s disease therapy?
Viviana Brembati, Gaia Faustini, Francesca Longhena, et al.
Frontiers in Molecular Neuroscience (2023) Vol. 16
Open Access | Times Cited: 18
Cross-sectional proteomic expression in Parkinson's disease-related proteins in drug-naïve patients vs healthy controls with longitudinal clinical follow-up
Ilham Y. Abdi, Michael Bartl, Mohammed Dakna, et al.
Neurobiology of Disease (2023) Vol. 177, pp. 105997-105997
Open Access | Times Cited: 17
RNA G-quadruplexes form scaffolds that promote neuropathological α-synuclein aggregation
Kazuya Matsuo, Sefan Asamitsu, K. Maeda, et al.
Cell (2024)
Open Access | Times Cited: 7
Lysosomal and synaptic dysfunction markers in longitudinal cerebrospinal fluid of de novo Parkinson’s disease
Michael Bartl, Johanna Nilsson, Mohammed Dakna, et al.
npj Parkinson s Disease (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 6
Altered Protein Palmitoylation as Disease Mechanism in Neurodegenerative Disorders
Jakub Włodarczyk, Raja Bhattacharyya, Kim Doré, et al.
Journal of Neuroscience (2024) Vol. 44, Iss. 40, pp. e1225242024-e1225242024
Closed Access | Times Cited: 5
Uncovering the Molecular Link Between Lead Toxicity and Parkinson's Disease
Liana Shvachiy, Vera Geraldes, Tiago F. Outeiro
Antioxidants and Redox Signaling (2023) Vol. 39, Iss. 4-6, pp. 321-335
Closed Access | Times Cited: 11
Uncovering potential diagnostic and pathophysiological roles of α‐synuclein and DJ‐1 in melanoma
Agathe Quesnel, Leya Danielle Martin, Chaimaa Tarzi, et al.
Cancer Medicine (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 4
Alpha-synuclein-induced stress sensitivity renders the Parkinson’s disease brain susceptible to neurodegeneration
Modestos Nakos Bimpos, Katerina Karali, Christine Antoniou, et al.
Acta Neuropathologica Communications (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 4
Unveiling the Cutting Edge: Recent Developments in α-Synuclein Nano-biosensor Technology for Precision Diagnosis of Parkinson’s Disease
Romi Shreshtha, Aditya Mulukutla, Vishal Kumar Deb, et al.
BioNanoScience (2025) Vol. 15, Iss. 1
Closed Access
Page 1 - Next Page

Scroll to top